Literature DB >> 21562036

Primary central nervous system lymphomas: a validation study of array-based comparative genomic hybridization in formalin-fixed paraffin-embedded tumor specimens.

Esteban Braggio1, Ellen Remstein McPhail, William Macon, M Beatriz Lopes, David Schiff, Mark Law, Stephanie Fink, Debra Sprau, Caterina Giannini, Ahmet Dogan, Rafael Fonseca, Brian Patrick O'Neill.   

Abstract

PURPOSE: Only a limited number of genetic studies have been conducted in primary central nervous system lymphomas (PCNSL), partly due to the rarity of the tumors and the very limited amount of available tissue. In this report, we present the first molecular characterization of copy number abnormalities (CNA) of newly diagnosed PCNSL by array-based comparative genomic hybridization (aCGH) in formalin-fixed paraffin-embedded (FFPE) specimens and compare the results with matched, frozen tumor specimens. EXPERIMENTAL
DESIGN: We conducted aCGH in FFPE tissues from PCNSL. Results were compared with matched, paired, frozen tumors.
RESULTS: Our analysis confirmed the good to fair quality and reliability of the data generated from limited amounts of tumoral FFPE tissue. Overall, all PCNSL cases were characterized by highly complex karyotypes, with a median of 23 CNAs per patient (range, 17-47). Overall, 20 chromosomal regions were recurrently found in more than 40% of cases. Deletions of 6p21, 6q, and 9p21.3 and gain of 12q12-q24.33 were the commonest CNAs. Other minimal affected regions were defined, and novel recurrent CNAs affecting single genes were identified in 3q26.32 (TBL1XR1) and 8q12.1 (TOX).
CONCLUSIONS: The results obtained are encouraging. Larger archival tissue collections can now be analyzed to complement the still fragmented knowledge we have of the genetic basis of the PCNSL.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21562036      PMCID: PMC3131452          DOI: 10.1158/1078-0432.CCR-11-0395

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  33 in total

1.  Neurocognitive outcomes in primary CNS lymphoma (PCNSL).

Authors:  Brian Patrick O'Neill
Journal:  Neurology       Date:  2004-02-24       Impact factor: 9.910

2.  Array-based DNA methylation profiling of primary lymphomas of the central nervous system.

Authors:  Julia Richter; Ole Ammerpohl; José I Martín-Subero; Manuel Montesinos-Rongen; Marina Bibikova; Eliza Wickham-Garcia; Otmar D Wiestler; Martina Deckert; Reiner Siebert
Journal:  BMC Cancer       Date:  2009-12-21       Impact factor: 4.430

Review 3.  Primary central nervous system lymphoma.

Authors:  Elizabeth R Gerstner; Tracy T Batchelor
Journal:  Arch Neurol       Date:  2010-03

4.  The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis.

Authors:  Janet E Olson; Carol A Janney; Ravi D Rao; James R Cerhan; Paul J Kurtin; David Schiff; Richard S Kaplan; Brian Patrick O'Neill
Journal:  Cancer       Date:  2002-10-01       Impact factor: 6.860

5.  Random DNA fragmentation allows detection of single-copy, single-exon alterations of copy number by oligonucleotide array CGH in clinical FFPE samples.

Authors:  Galen Hostetter; Su Young Kim; Stephanie Savage; Gerald C Gooden; Michael Barrett; Jian Zhang; Lalitamba Alla; April Watanabe; Janine Einspahr; Anil Prasad; Brian J Nickoloff; John Carpten; Jeffrey Trent; David Alberts; Michael Bittner
Journal:  Nucleic Acids Res       Date:  2009-10-29       Impact factor: 16.971

6.  Chromosomal imbalances and partial uniparental disomies in primary central nervous system lymphoma.

Authors:  H Schwindt; I Vater; M Kreuz; M Montesinos-Rongen; A Brunn; J Richter; S Gesk; O Ammerpohl; O D Wiestler; D Hasenclever; M Deckert; R Siebert
Journal:  Leukemia       Date:  2009-06-04       Impact factor: 11.528

7.  Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstrom's macroglobulinemia.

Authors:  Esteban Braggio; Jonathan J Keats; Xavier Leleu; Scott Van Wier; Victor H Jimenez-Zepeda; Riccardo Valdez; Roelandt F J Schop; Tammy Price-Troska; Kimberly Henderson; Antonio Sacco; Feda Azab; Philip Greipp; Morie Gertz; Suzanne Hayman; S Vincent Rajkumar; John Carpten; Marta Chesi; Michael Barrett; A Keith Stewart; Ahmet Dogan; P Leif Bergsagel; Irene M Ghobrial; Rafael Fonseca
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

8.  Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.

Authors:  Christine P Hans; Dennis D Weisenburger; Timothy C Greiner; Randy D Gascoyne; Jan Delabie; German Ott; H Konrad Müller-Hermelink; Elias Campo; Rita M Braziel; Elaine S Jaffe; Zenggang Pan; Pedro Farinha; Lynette M Smith; Brunangelo Falini; Alison H Banham; Andreas Rosenwald; Louis M Staudt; Joseph M Connors; James O Armitage; Wing C Chan
Journal:  Blood       Date:  2003-09-22       Impact factor: 22.113

9.  Computer-assisted stereotaxic biopsy for the diagnosis of primary central nervous system lymphoma.

Authors:  B P O'Neill; P J Kelly; J D Earle; B Scheithauer; P M Banks
Journal:  Neurology       Date:  1987-07       Impact factor: 9.910

10.  A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors.

Authors:  Valentina Perissi; Aneel Aggarwal; Christopher K Glass; David W Rose; Michael G Rosenfeld
Journal:  Cell       Date:  2004-02-20       Impact factor: 41.582

View more
  31 in total

1.  TBL1XR1/TP63: a novel recurrent gene fusion in B-cell non-Hodgkin lymphoma.

Authors:  David W Scott; Karen L Mungall; Susana Ben-Neriah; Sanja Rogic; Ryan D Morin; Graham W Slack; King L Tan; Fong Chun Chan; Raymond S Lim; Joseph M Connors; Marco A Marra; Andrew J Mungall; Christian Steidl; Randy D Gascoyne
Journal:  Blood       Date:  2012-04-11       Impact factor: 22.113

Review 2.  Molecular diagnostics: techniques and recommendations for 1p/19q assessment.

Authors:  Adelheid Woehrer; Johannes A Hainfellner
Journal:  CNS Oncol       Date:  2015-11-06

3.  Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma.

Authors:  Christian Grommes; Alessandro Pastore; Nicolaos Palaskas; Sarah S Tang; Carl Campos; Derrek Schartz; Paolo Codega; Donna Nichol; Owen Clark; Wan-Ying Hsieh; Dan Rohle; Marc Rosenblum; Agnes Viale; Viviane S Tabar; Cameron W Brennan; Igor T Gavrilovic; Thomas J Kaley; Craig P Nolan; Antonio Omuro; Elena Pentsova; Alissa A Thomas; Elina Tsyvkin; Ariela Noy; M Lia Palomba; Paul Hamlin; Craig S Sauter; Craig H Moskowitz; Julia Wolfe; Ahmet Dogan; Minhee Won; Jon Glass; Scott Peak; Enrico C Lallana; Vaios Hatzoglou; Anne S Reiner; Philip H Gutin; Jason T Huse; Katherine S Panageas; Thomas G Graeber; Nikolaus Schultz; Lisa M DeAngelis; Ingo K Mellinghoff
Journal:  Cancer Discov       Date:  2017-06-15       Impact factor: 39.397

4.  Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma.

Authors:  Christian Grommes; Sarah S Tang; Julia Wolfe; Thomas J Kaley; Mariza Daras; Elena I Pentsova; Anna F Piotrowski; Jacqueline Stone; Andrew Lin; Craig P Nolan; Malbora Manne; Paolo Codega; Carl Campos; Agnes Viale; Alissa A Thomas; Michael F Berger; Vaios Hatzoglou; Anne S Reiner; Katherine S Panageas; Lisa M DeAngelis; Ingo K Mellinghoff
Journal:  Blood       Date:  2018-12-19       Impact factor: 22.113

5.  Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas.

Authors:  Esteban Braggio; Scott Van Wier; Juhi Ojha; Ellen McPhail; Yan W Asmann; Jan Egan; Jackline Ayres da Silva; David Schiff; M Beatriz Lopes; Paul A Decker; Riccardo Valdez; Raoul Tibes; Bruce Eckloff; Thomas E Witzig; A Keith Stewart; Rafael Fonseca; Brian Patrick O'Neill
Journal:  Clin Cancer Res       Date:  2015-05-19       Impact factor: 12.531

Review 6.  New approaches in primary central nervous system lymphoma.

Authors:  Eleanor Fraser; Katherine Gruenberg; James L Rubenstein
Journal:  Chin Clin Oncol       Date:  2015-03

Review 7.  TBL1XR1 in physiological and pathological states.

Authors:  Jian Yi Li; Garrett Daniels; Jing Wang; Xinmin Zhang
Journal:  Am J Clin Exp Urol       Date:  2015-04-25

8.  The mutational pattern of primary lymphoma of the central nervous system determined by whole-exome sequencing.

Authors:  I Vater; M Montesinos-Rongen; M Schlesner; A Haake; F Purschke; R Sprute; N Mettenmeyer; I Nazzal; I Nagel; J Gutwein; J Richter; I Buchhalter; R B Russell; O D Wiestler; R Eils; M Deckert; R Siebert
Journal:  Leukemia       Date:  2014-09-05       Impact factor: 11.528

9.  A novel IGH@ gene rearrangement associated with CDKN2A/B deletion in young adult B-cell acute lymphoblastic leukemia.

Authors:  Moneeb A K Othman; Beata Grygalewicz; Barbara Pienkowska-Grela; Jolanta Rygier; Anna Ejduk; Martina Rincic; Joana B Melo; Isabel M Carreira; Britta Meyer; Thomas Liehr
Journal:  Oncol Lett       Date:  2016-01-29       Impact factor: 2.967

10.  Identification of novel recurrent ETV6-IgH fusions in primary central nervous system lymphoma.

Authors:  Aurélie Bruno; Karim Labreche; Maïlys Daniau; Blandine Boisselier; Guillaume Gauchotte; Louis Royer-Perron; Amithys Rahimian; Frédéric Lemoine; Pierre de la Grange; Justine Guégan; Franck Bielle; Marc Polivka; Clovis Adam; David Meyronet; Dominique Figarella-Branger; Chiara Villa; Fabrice Chrétien; Sandrine Eimer; Frédéric Davi; Audrey Rousseau; Caroline Houillier; Carole Soussain; Karima Mokhtari; Khê Hoang-Xuan; Agusti Alentorn
Journal:  Neuro Oncol       Date:  2018-07-05       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.